Detalhe da pesquisa
1.
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.
Blood
; 135(20): 1759-1771, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32187361
2.
Comparative analysis of gene expression platforms for cell-of-origin classification of diffuse large B-cell lymphoma shows high concordance.
Br J Haematol
; 192(3): 599-604, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33249557
3.
Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression.
Blood
; 126(21): 2362-5, 2015 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26392596
4.
Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome.
Br J Haematol
; 159(4): 441-53, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22970711
5.
Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network.
Blood Adv
; 6(21): 5716-5731, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363872
6.
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).
Blood
; 112(6): 2248-60, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18612102
7.
Practical Application of Fluorescent In Situ Hybridization Techniques in Clinical Diagnostic Laboratories.
Methods Mol Biol
; 2148: 35-70, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32394374
8.
Deregulated over expression of FOXP1 protein in diffuse large B-cell lymphoma does not occur as a result of gene rearrangement.
Haematologica
; 92(6): 863-4, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17550867
9.
The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.
Clin Cancer Res
; 9(6): 2133-9, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12796378
10.
Dysregulation of apoptosis in Waldenstrom's macroglobulinemia does not involve nuclear factor kappa B activation.
Semin Oncol
; 30(2): 161-4, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12720128
11.
The detection of t(14;18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction.
J Mol Diagn
; 5(3): 168-75, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12876207
12.
The t(9;14)(p13;q32) is a recurrent but rare abnormality in splenic marginal zone lymphoma.
Leuk Lymphoma
; 48(8): 1636-7, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17701598
13.
t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma.
Genes Chromosomes Cancer
; 45(2): 164-8, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16252263
14.
Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.
Blood
; 104(9): 2933-5, 2004 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15238418
15.
Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma.
Blood
; 99(4): 1136-43, 2002 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11830458
16.
Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma.
Br J Haematol
; 117(2): 322-32, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11972514
17.
RAG1 and BRCA2 polymorphisms in non-Hodgkin lymphoma.
Blood
; 109(12): 5522-3, 2007 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17554067